Yinchen Shen

986 total citations
60 papers, 682 citations indexed

About

Yinchen Shen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yinchen Shen has authored 60 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Yinchen Shen's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Yinchen Shen is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Yinchen Shen collaborates with scholars based in China, United States and India. Yinchen Shen's co-authors include Xiaohong Han, Xun Xu, Yuankai Shi, Shuai Wang, Jianfei Wang, Kun Liu, Changhui Li, Fang Hu, Xueyan Zhang and Dongmei Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Yinchen Shen

54 papers receiving 677 citations

Peers

Countries citing papers authored by Yinchen Shen

Since Specialization

Citations

This map shows the geographic impact of Yinchen Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinchen Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinchen Shen more than expected).

Fields of papers citing papers by Yinchen Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinchen Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinchen Shen. The network helps show where Yinchen Shen may publish in the future.

Co-authorship network of co-authors of Yinchen Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yinchen Shen. A scholar is included among the top collaborators of Yinchen Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinchen Shen. Yinchen Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic role of serum cytokines level in non-small cell lung cancer patients with anti-PD-1 and chemotherapy combined treatment 2024 ·Frontiers in Immunology ·Hongyu Liu, Chao Zhou, (unknown), Tianqing Chu, Runbo Zhong, Xueyan Zhang, Yinchen Shen, (unknown)	3
2	Metadata information and fundus image fusion neural network for hyperuricemia classification in diabetes 2024 ·Computer Methods and Programs in Biomedicine ·(unknown), Yupeng Xu, Hanying Wang, (unknown), (unknown), Yinchen Shen, (unknown), (unknown), (unknown), Lei Bi, Xun Xu, Yufan Wang, Kun Liu	2
3	Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer 2024 ·Journal for ImmunoTherapy of Cancer ·Liang Zheng, Fang Hu, Lin Huang, Jun Lü, Xiaohua Yang, Jianlin Xu, Shuyuan Wang, Yinchen Shen, Runbo Zhong, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, (unknown), Hua Zhong, Wei Nie, Xueyan Zhang	6
4	Quantitative evaluation of ocular vascularity and correlation analysis in patients with diabetic retinopathy by SMI and OCTA 2024 ·BMC Ophthalmology ·(unknown), Chong Chen, Yinchen Shen, Fang Li, (unknown), Haiyun Liu	3
5	UCP2–SIRT3 Signaling Relieved Hyperglycemia-Induced Oxidative Stress and Senescence in Diabetic Retinopathy 2024 ·Investigative Ophthalmology & Visual Science ·Shenping Li, Dandan Sun, (unknown), Shuchang Zhang, Qing Gu, Yinchen Shen, Xu Li, Xun Xu, Fang Wei, Ning Wang	10
6	Neoadjuvant immunology therapy in patients with non-small cell lung cancer and chronic obstructive pulmonary disease 2024 ·Journal of Thoracic Disease ·Qing Chang, Jiaqi Li, Yan Zhu, Huiping Qiang, Haijiao Lu, Yinchen Shen, Shuyuan Wang, Jialin Qian, Tianqing Chu	0
7	Association analysis between chromosomal abnormalities and fetal ultrasonographic soft markers based on 15,263 fetuses 2023 ·American Journal of Obstetrics & Gynecology MFM ·Lijuan Pan, Jiayu Wu, Desheng Liang, Jing Yuan, Jue Wang, Yinchen Shen, Junjie Lu, Aihua Xia, Jinchen Li, Lingqian Wu	11
8	Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy 2022 ·Frontiers in Oncology ·Huiping Qiang, Jiaqi Li, Qing Chang, Yinchen Shen, Jialin Qian, Tianqing Chu	8
9	Comprehensive Analysis of the Immune Cell Infiltration Landscape and Immune-Related Methylation in Retinoblastoma 2022 ·Frontiers in Genetics ·(unknown), Yinchen Shen, Xun Xu, Jiawei Zhong	5
10	Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy 2021 ·Translational Lung Cancer Research ·Xin Yu, Jiaqi Li, Lingyun Ye, Jing Zhao, (unknown), Juan Zhou, Yinchen Shen, Fei Zhou, Yan Wu, (unknown), Jialin Qian, Tianqing Chu, Chunxia Su	13
11	Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery 2021 ·Lung Cancer ·(unknown), Changhui Li, Jianlin Xu, Xiaohua Yang, Wei Nie, Hua Zhong, Tianqing Chu, Wei Zhang, Runbo Zhong, Feng Pan, Yinchen Shen, Yuqing Lou, Bo Zhang, Baohui Han, Xueyan Zhang	2
12	Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion 2020 ·Respiratory Research ·Hai Zhang, Changhui Li, Fang Hu, Xueyan Zhang, Yinchen Shen, Yuqing Chen, Feng Li	18
13	Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery 2020 ·Lung Cancer ·Changhui Li, Yinchen Shen, Fang Hu, Tianqing Chu, Xiaohua Yang, Jinchen Shao, Xiaoxuan Zheng, Jianlin Xu, Hai Zhang, Baohui Han, Hua Zhong, Xueyan Zhang	13
14	Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma 2019 ·Targeted Oncology ·Changhui Li, Bo Zhang, (unknown), Fang Hu, Wei Nie, Xiaoxuan Zheng, Lixin Wang, Yuqing Lou, Yinchen Shen, Baohui Han, Xueyan Zhang	4
15	Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns 2019 ·Journal of Cancer ·Fang Hu, Bo Zhang, Changhui Li, Jianlin Xu, Huimin Wang, Ping Gu, Xiaoxuan Zheng, Wei Nie, Yinchen Shen, Hai Zhang, Ping Hu, Xueyan Zhang	1
16	Pro‐apoptotic effects of micro‐ribonucleic acid‐365 on retinal neurons by targeting insulin‐like growth factor‐1 in diabetic rats: An in vivo and in vitro study 2018 ·Journal of Diabetes Investigation ·(unknown), (unknown), Yinchen Shen, Zhihua Zhang, Qing Gu, Xu Xu, Qing Qin, (unknown)	7
17	Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations 2018 ·Clinical Lung Cancer ·Fang Hu, Jianlin Xu, Bo Zhang, Changhui Li, Wei Nie, Ping Gu, Ping Hu, Huimin Wang, Yujun Zhang, Yinchen Shen, Shuyuan Wang, Xueyan Zhang	42
18	CRM1 as a new therapeutic target for non-Hodgkin lymphoma 2014 ·Leukemia Research ·Xiaohong Han, Jianfei Wang, Yinchen Shen, Ningning Zhang, Shuai Wang, Jiarui Yao, Yuankai Shi	19
19	Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Population 2014 ·Translational Oncology ·Xiaohong Han, Zhishang Zhang, Di Wu, Yinchen Shen, Shuai Wang, Lin Wang, Yutao Liu, Sheng Yang, Xingsheng Hu, Yun Feng, Yan Sun, Yuankai Shi	9
20	Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers 2013 ·Biomedicine & Pharmacotherapy ·Ning Li, Yuanyuan Song, Ping Du, Yinchen Shen, Jianliang Yang, Lin Gui, Shuai Wang, Jianfei Wang, Yan Sun, Xiaohong Han, Yuankai Shi	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact